End-of-day quote
Shanghai S.E.
18:00:00 2024-05-12 EDT
|
5-day change
|
1st Jan Change
|
4.74
CNY
|
-7.24%
|
|
+9.72%
|
-19.39%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
2,495
|
2,798
|
2,464
|
2,749
|
4,066
|
2,557
|
Enterprise Value (EV)
1 |
2,189
|
2,415
|
1,878
|
2,184
|
3,375
|
2,213
|
P/E ratio
|
9.95
x
|
13.6
x
|
13.9
x
|
15.5
x
|
10.6
x
|
-25.6
x
|
Yield
|
-
|
1.2%
|
2.25%
|
2.02%
|
1.91%
|
-
|
Capitalization / Revenue
|
1.53
x
|
1.78
x
|
1.3
x
|
1.25
x
|
1.3
x
|
1.03
x
|
EV / Revenue
|
1.34
x
|
1.53
x
|
0.99
x
|
0.99
x
|
1.08
x
|
0.89
x
|
EV / EBITDA
|
7.08
x
|
8.57
x
|
6.77
x
|
8.47
x
|
6.43
x
|
78.2
x
|
EV / FCF
|
-9.43
x
|
24.8
x
|
9.22
x
|
-35.1
x
|
26.5
x
|
-14.2
x
|
FCF Yield
|
-10.6%
|
4.03%
|
10.8%
|
-2.85%
|
3.78%
|
-7.02%
|
Price to Book
|
1.84
x
|
1.8
x
|
1.45
x
|
1.5
x
|
1.87
x
|
1.28
x
|
Nbr of stocks (in thousands)
|
430,259
|
430,259
|
434,897
|
434,897
|
434,858
|
434,813
|
Reference price
2 |
5.800
|
6.502
|
5.667
|
6.321
|
9.350
|
5.880
|
Announcement Date
|
19-04-09
|
20-04-27
|
21-04-26
|
22-04-25
|
23-04-25
|
24-04-29
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
1,636
|
1,575
|
1,896
|
2,203
|
3,126
|
2,482
|
EBITDA
1 |
309.1
|
281.8
|
277.4
|
257.7
|
524.6
|
28.3
|
EBIT
1 |
273.7
|
242.9
|
228.1
|
178.3
|
411.3
|
-139.6
|
Operating Margin
|
16.73%
|
15.42%
|
12.03%
|
8.1%
|
13.16%
|
-5.62%
|
Earnings before Tax (EBT)
1 |
293.6
|
239.1
|
214.7
|
201.8
|
412.8
|
-125.2
|
Net income
1 |
251
|
204.6
|
176
|
177.4
|
381.2
|
-97.89
|
Net margin
|
15.35%
|
13%
|
9.29%
|
8.05%
|
12.19%
|
-3.94%
|
EPS
2 |
0.5831
|
0.4764
|
0.4082
|
0.4082
|
0.8786
|
-0.2300
|
Free Cash Flow
1 |
-232.1
|
97.36
|
203.7
|
-62.23
|
127.5
|
-155.3
|
FCF margin
|
-14.19%
|
6.18%
|
10.74%
|
-2.83%
|
4.08%
|
-6.26%
|
FCF Conversion (EBITDA)
|
-
|
34.55%
|
73.43%
|
-
|
24.31%
|
-
|
FCF Conversion (Net income)
|
-
|
47.58%
|
115.7%
|
-
|
33.45%
|
-
|
Dividend per Share
|
-
|
0.0781
|
0.1276
|
0.1276
|
0.1786
|
-
|
Announcement Date
|
19-04-09
|
20-04-27
|
21-04-26
|
22-04-25
|
23-04-25
|
24-04-29
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
306
|
383
|
586
|
566
|
690
|
344
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-232
|
97.4
|
204
|
-62.2
|
128
|
-155
|
ROE (net income / shareholders' equity)
|
20.3%
|
14%
|
10.8%
|
10%
|
19%
|
-4.54%
|
ROA (Net income/ Total Assets)
|
11%
|
7.53%
|
6.15%
|
4.41%
|
8.46%
|
-2.62%
|
Assets
1 |
2,278
|
2,719
|
2,864
|
4,027
|
4,507
|
3,742
|
Book Value Per Share
2 |
3.150
|
3.620
|
3.920
|
4.230
|
5.000
|
4.610
|
Cash Flow per Share
2 |
0.7100
|
1.200
|
1.160
|
1.350
|
1.790
|
1.490
|
Capex
1 |
328
|
336
|
129
|
198
|
298
|
192
|
Capex / Sales
|
20.02%
|
21.31%
|
6.82%
|
9%
|
9.53%
|
7.72%
|
Announcement Date
|
19-04-09
|
20-04-27
|
21-04-26
|
22-04-25
|
23-04-25
|
24-04-29
|
|
1st Jan change
|
Capi.
|
---|
| -19.39% | 285M | | +3.33% | 3.66B | | -19.60% | 2.17B | | -7.64% | 1.97B | | +3.66% | 1.89B | | +0.22% | 1.71B | | -1.15% | 1.32B | | +5.69% | 1.2B | | -18.30% | 1.08B | | -0.17% | 1.03B |
Pesticide
|